Cartesian Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -7.08%
- Market cap
- $194.30M
- 30.5M shares
- Filings
- 877
Q3 2026−92.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−41.1% FY25 yoy
- $194.30M
- —
- 81.1×
- —
- -46.26%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,797,000 | reported | |
| FY 2024 | 2024-12-31 | $38,913,000 | reported | |
| FY 2023 | 2023-12-31 | $26,004,000 | reported | |
| FY 2022 | 2022-12-31 | $110,777,000 | reported | |
| FY 2021 | 2021-12-31 | $85,077,000 | reported | |
| FY 2020 | 2020-12-31 | $16,597,000 | reported | |
| FY 2019 | 2019-12-31 | $6,677,000 | reported | |
| FY 2018 | 2018-12-31 | $903,000 | reported | |
| FY 2017 | 2017-12-31 | $207,000 | reported | |
| FY 2016 | 2016-12-31 | $8,083,000 | reported | |
| FY 2015 | 2015-12-31 | $6,011,000 | reported | |
| FY 2014 | 2014-12-31 | $3,040,000 | reported |
Segments
Segments
LineFY2025ShareChange
Operating Segment$400.00K100%−99.0%
Reporting Segments———
Total$400.00K
Pharmaceutical preparations
Cartesian Therapeutics, Inc. is the 197th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MRKRMarker Therapeutics, Inc.$3.5M46.2%343.0%$15.0MCAMPCamp4 Therapeutics Corp$3.5M436.5%2,298.5%$254.8MTXMDTherapeuticsMD, Inc.$3.0M71.6%18.8%$20.9MXBIOXenetic Biosciences, Inc.$3.0M19.0%90.1%$4.3MUPBUpstream Bio, Inc.$2.9M20.4%5,026.0%$156.5M
RNACCartesian Therapeutics, Inc. (this company)$2.8M92.8%4,658.6%$194.3M
TRAWTraws Pharma, Inc.$2.8M1,134.5%328.7%$4.2MGOVXGeoVax Labs, Inc.$2.5M37.1%862.3%$1.1MKRSAKorsana Biosciences, Inc.$2.1M3.7%170.1%$1.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cartesian Therapeutics, Inc. · CIK 1453687 · Engraved from SEC EDGAR